Clinical Trials on Non Erosive Reflux Disease in France

Total 2118 results

AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
Nantes University Hospital

Completed

Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects (Oberab)

Gastroesophageal Reflux

France
Erasme University Hospital
EndoStim Inc.

Terminated

Electrical Stimulation Therapy (EST) of the Lower Esophageal Sphincter (GERD) (EST-SHAM-EUR)

GERD

Belgium, France
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Nantes University Hospital

Completed

Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.

Urinary Tract Infection

France
Johns Hopkins University
EndoGastric Solutions

Enrolling by invitation

The Johns Hopkins Heartburn Center Registry

Esophagitis | Gastroesophageal Reflux Disease | Barrett Esophagus | Laryngopharyngeal Reflux

United States
Centre Hospitalier Departemental Vendee
Institut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaborators

Terminated

Impact of Early Enteral vs. Parenteral Nutrition on Risk of Gastric-Content Aspiration in Patients Requiring Mechanical Ventilation and Catecholamines

Shock | Acute Respiratory Failure

France
Hoffmann-La Roche

Completed

Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

France
Centre Leon Berard
CREATIS Laboratory

Completed

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma (midP)

Non-small Cell Lung Cancer | Radiation Therapy | Locally Advanced Disease | Non-metastatic Disease | Non-resectable Disease

France
AstraZeneca

Completed

National Survey on GERD Patients (Adults and Children) (RGO à trav)

GERD (Gastroesophageal Reflux Disease)

France
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Assistance Publique - Hôpitaux de Paris

Recruiting

Jejunal Feeding Via Gastrojejunal Tube in Refractory Gastroesophageal Reflux (ReJej)

Gastroesophageal Reflux

France
Assistance Publique Hopitaux De Marseille

Completed

Prognosis of Isolated Left Ventricular Non-compaction in Adults (NCVG)

Left Ventricular Non Compaction

France
Centre Hospitalier Universitaire de Nice

Completed

Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH

Non Alcoholic Fatty Liver Disease

France
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease (PANDA)

Gastroesophageal Reflux Disease

Brazil
University Hospital, Angers

Recruiting

UDFF Performance Evaluation ((Ultrason Derived Fat Fraction) (UDFF)

Non Alcoholic Fatty Liver Disease

France
Takeda

Completed

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Association pour la Recherche sur les Maladies...

Completed

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis (FLIRT)

Non Alcoholic Steatohepatitis

France
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients

Photosensitive Epilepsy

France, Germany
AstraZeneca

Completed

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

Gastroesophageal Reflux Disease (GERD)

Hungary, Romania, Norway, Belgium, France, Netherlands, Germany, Australia
Assistance Publique - Hôpitaux de Paris
Institute of Cardiometabolism and Nutrition, France

Recruiting

NASH and Coronary Disease (CORO-NASH)

Non-Alcoholic Fatty Liver Disease

France
Centre Hospitalier Universitaire Dijon

Recruiting

Living Conditions After Non-Hodgkin's Lymphoma in France (LymphoVie 2)

Non-hodgkin's Lymphoma

France
Institut Paoli-Calmettes

Completed

Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma (R2)

Non-Hodgkin Lymphoma

France
Centre Hospitalier Universitaire de Nice

Recruiting

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease (STEATO-APA)

Non-Alcoholic Fatty Liver Disease (NAFLD

France
University Hospital, Toulouse

Recruiting

Porphyromonas Gingivalis and Severity of Fibrosis in Patients With Non-alcoholic Fatty Liver Disease (BUCCONAFLD)

Non-Alcoholic Fatty Liver Disease

France
University Hospital, Montpellier

Completed

Comparison of Three Noninvasive Ventilation Modes: a Physiological Study in Healthy Volunteers

Respiratory Failure | Non Invasive Ventilation on Healthy Volunteer

France
Janssen Research & Development, LLC
Eisai Inc.

Completed

A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

Gastroesophageal Reflux Disease (GERD)

United States, Poland, United Kingdom, Belgium, Brazil
Centre Hospitalier Universitaire de Nice

Recruiting

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma (CART-Omic)

Refractory or Relapsed Non-Hodgkin's Lymphoma

France
Hospices Civils de Lyon

Completed

Covert Saccade Triggers in Bilateral Vestibular Hypofunction (CS-TRIGGER)

Healthy Volunteers | Bilateral Vestibulopathy | Reflex, Abnormal

France
Assistance Publique - Hôpitaux de Paris

Completed

Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment (IDeATIon)

Glioma | Non Small Cell Lung Cancer | Non Hodgkin Lymphoma

France
Assistance Publique - Hôpitaux de Paris

Completed

Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients (FIRM)

Morbid Obesity | Non Alcoholic Steatohepatitis

France
Hoffmann-La Roche

Completed

A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

France
E-Scopics
University Hospital, Bordeaux

Completed

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation (DIACEPA)

Liver Diseases | Liver Cirrhosis | Non-Alcoholic Fatty Liver Disease

France
Centre Leon Berard
Amgen

Terminated

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation (PALM2)

Non Hodgkin Lymphoma

France
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Institut Bergonié
National Cancer Institute, France

Completed

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial (FRAIL-06)

Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris
Novartis

Unknown

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (RAD001)

Non-small Cell Lung Cancer | Locally Advanced Disease

France
Hospices Civils de Lyon

Recruiting

Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis (Profil-NASH)

Liver Diseases

France
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb

Terminated

Tumor Mutational Burden in Lung Cancer Patients (MUBULUC)

Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IV | Non Small Cell Lung Cancer Stage III | Non-Small Cell Carcinoma of Lung

France
Eisai Inc.

Completed

Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)

Chile, Canada, United States, Estonia, India, Hungary, Bulgaria, Croatia, Australia, Lithuania, Latvia, Argentina, France, Germany
University Hospital, Montpellier

Recruiting

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping (CLIPPCAIR)

Non-small Cell Lung Cancer

France
Hopital Foch

Unknown

Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection (Onco-VOC)

Lung Cancer, Non-small Cell

France
University Hospital, Montpellier

Completed

Texture Features and PDL1 in CT-PET 18 FDG

Non Small Cell Lung Cancer

France
University of Paris 5 - Rene Descartes

Completed

Hypermetabolism in the Elderly Lung Cancer Patient (HELP)

Non-small Cell Lung Carcinoma

France
Centre Hospitalier Universitaire de Nice

Unknown

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

Non Small Cell Lung Cancer

France
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Sanofi

Completed

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (GON)

Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris
AstraZeneca

Recruiting

Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by Electroporation Ablation (DUMELEP)

BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR)

Non-small Cell Lung Cancer

France
Hopital Foch

Terminated

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)

Lung Cancer, Non-small Cell

France

3

Subscribe